非酒精性脂肪肝相关慢性肾病发病机制进展
Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease
摘要: 随着肥胖和2型糖尿病(Type 2 Diabetes Mellitus, T2DM)发病率的上升,非酒精性脂肪肝(Non-alcoholic Fatty Liver Disease, NAFLD)已经成为全球最常见的慢性肝病。NAFLD是一种多系统疾病,与代谢综合征、心血管疾病,慢性肾脏病密切关联。近年来,慢性肾脏病(Chronic Kidney Disease, CKD)患病率逐年上升,已成为全球性的公共卫生问题,严重威胁人体健康。很多研究表明,NAFLD与肾功能受损相关。肾脏损伤的早期表现为足细胞损伤和蛋白尿。因此,NAFLD与CKD逐渐成为学者们关注的热点。我们推测NAFLD与CKD之间存在共同发病机制。本文目的在于对非酒精性脂肪肝推测相关慢性肾病发病机制进行综述。
Abstract: With the increase of obesity and Type 2 Diabetes Mellitus (T2DM), non-alcoholic Fatty Liver Disease (NAFLD) has become the most common chronic Liver Disease in the world. NAFLD is a multisystem disease closely associated with metabolic syndrome, cardiovascular disease and chronic kidney disease. In recent years, the prevalence of chronic kidney disease (CKD) increases year by year, which has become a global public health problem and a serious threat to human health. Many studies have shown that NAFLD is associated with impaired renal function. The early manifestations of kidney injury are podocyte injury and proteinuria. Therefore, NAFLD and CKD have gradually become the focus of attention of scholars. We speculate that there is a common pathogenesis between NAFLD and CKD. The purpose of this article is to summarize the pathogenesis of CKD associated with NAFLD.
文章引用:宋清莲, 袁贝贝, 刘京京, 刘万里, 戴光荣. 非酒精性脂肪肝相关慢性肾病发病机制进展[J]. 临床医学进展, 2019, 9(9): 1073-1079. https://doi.org/10.12677/ACM.2019.99165

参考文献

[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 实用肝脏病杂志, 2018, 21(2): 177-186.
[2] 孙长贵, 曾静, 孙婉璐, 等. 非酒精性脂肪性肝病患者估算的肾小球滤过率的变化及其影响因素分析[J]. 实用肝脏病杂志, 2017, 20(2): 165-170.
[3] Wensveen, S.T., et al. (2016) Nonalcoholic Fatty Liver Disease—A Multisystem Disease? World Journal of Gastroenterology, 22, 9488-9505. [Google Scholar] [CrossRef] [PubMed]
[4] Eugene, H. and Yong-Ho, L. (2017) Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases. Diabetes & Metabolism Journal, 41, 430-437. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, J., Zhang, X., Zhao, Y., et al. (2018) Association between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Annals of Nutrition and Metabolism, 72, 30-36. [Google Scholar] [CrossRef] [PubMed]
[6] Targher, G. and Byrne, C.D. (2017) Non-Alcoholic Fatty Liver Disease: An Emerging Driving Force in Chronic Kidney Disease. Nature Reviews Nephrology, 13, 297-310. [Google Scholar] [CrossRef] [PubMed]
[7] Dowman, J.K., Tomlinson, J.W. and Newsome, P.N. (2010) Pathogenesis of Non-Alcoholic Fatty Liver Disease. QJM, 103, 71-83. [Google Scholar] [CrossRef] [PubMed]
[8] Tanaka, N., Kimura, T., Fujimori, N., et al. (2019) Current Status, Problems, and Perspectives of Non-Alcoholic Fatty Liver Disease Research. World Journal of Gastroenterology, 25, 163-177. [Google Scholar] [CrossRef] [PubMed]
[9] Perry, R.J., Samuel, V.T., Petersen, K.F., et al. (2014) The Role of Hepatic Lipids in Hepatic Insulin Resistance and Type 2 Diabetes. Nature, 510, 84-91. [Google Scholar] [CrossRef] [PubMed]
[10] Dongiovanni, P., Meroni, M., Baselli, G.A., et al. (2017) Insulin Resistance Promotes Lysyl Oxidase like 2 Induction and Fibrosis Accumulation in Nonalcoholic Fatty Liver Disease. Clinical Science, 131, 1301-1315. [Google Scholar] [CrossRef
[11] Spoto, B., Pisano, A. and Zoccali, C. (2016) Insulin Resistance in Chronic Kidney Disease: A Systematic Review. AJP Renal Physiology, 311, F1087-F1108. [Google Scholar] [CrossRef] [PubMed]
[12] Hayashi, K., Kanda, T., Homma, K., et al. (2002) Altered Renal Microvascular Response in Zucker Obese Rats. Metabolism—Clinical & Experimental, 51, 1553-1561. [Google Scholar] [CrossRef] [PubMed]
[13] Irsik, D.L., Chen, J.K. and Brands, M.W. (2018) Chronic Renal Artery Insulin Infusion Increases Mean Arterial Pressure in Male Sprague Dawley Rats. American Journal of Physiology—Renal Physiology, 314, F81-F88. [Google Scholar] [CrossRef] [PubMed]
[14] Welsh, G.I., Hale, L.J., Eremina, V., et al. (2010) Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function. Cell Metabolism, 12, 329-340. [Google Scholar] [CrossRef] [PubMed]
[15] Lay, A.C., Hurcombe, J.A., Betin, V.M.S., et al. (2017) Prolonged Exposure of Mouse and Human Podocytes to Insulin Induces Insulin Resistance through Lysosomal and Proteasomal Degradation of the Insulin Receptor. Diabetologia, 60, 2299-2311. [Google Scholar] [CrossRef] [PubMed]
[16] Saleem, M.A. (2005) The Human Glomerular Podocyte Is a Novel Target for Insulin Action. Diabetes, 54, 3095-3102. [Google Scholar] [CrossRef] [PubMed]
[17] Marra, F. and Svegliati-Baroni, G. (2018) Lipotoxicity and the Gut-Liver Axis in NASH Pathogenesis. Journal of Hepatology, 68, 280-295. [Google Scholar] [CrossRef] [PubMed]
[18] Hebbard, L. and George, J. (2011) Animal Models of Nonalcoholic Fatty Liver Disease. Nature Reviews Gastroenterology & Hepatology, 8, 35-44. [Google Scholar] [CrossRef] [PubMed]
[19] Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism—Clinical & Experimental, 65, 1038-1048. [Google Scholar] [CrossRef] [PubMed]
[20] Peter, M., Matthew, D., Suet-Wan, C., et al. (2015) Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism. Metabolites, 5, 720-732. [Google Scholar] [CrossRef] [PubMed]
[21] Bowe, B., Xie, Y., Xian, H., et al. (2016) Low Levels of High-Density Lipoprotein Cholesterol Increase the Risk of Incident Kidney Disease and Its Progression. Kidney International, 89, 886-896. [Google Scholar] [CrossRef] [PubMed]
[22] Tao, J.L., Wen, Y.B., Shi, B.Y., et al. (2012) Endoplasmic Reticulum Stress Is Involved in Podocyte Apoptosis Induced by Saturated Fatty Acid Palmitate. Chinese Medical Journal, 125, 3137-3142.
[23] Abrass, C.K. (2004) Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease. American Journal of Nephrology, 24, 46-53. [Google Scholar] [CrossRef] [PubMed]
[24] Wahl, P., Ducasa, G.M. and Fornoni, A. (2016) Systemic and Renal Lipids in Kidney Disease Development and Progression. American Journal of Physiology Renal Physiology, 310, F433-F445. [Google Scholar] [CrossRef] [PubMed]
[25] Cao, Y., Hao, Y., Li, H., et al. (2014) Role of Endoplasmic Reticulum Stress in Apoptosis of Differentiated Mouse Podocytes Induced by High Glucose. International Journal of Molecular Medicine, 33, 809-816. [Google Scholar] [CrossRef] [PubMed]
[26] Kaysen, G.A. (2009) New Insights into Lipid Metabolism in Chronic Kidney Disease: What Are the Practical Implications? Blood Purification, 27, 86-91. [Google Scholar] [CrossRef] [PubMed]
[27] Stern, J.H., Rutkowski, J.M. and Scherer, P.E. (2016) Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metabolism, 23, 770-784. [Google Scholar] [CrossRef] [PubMed]
[28] Jung, U. and Choi, M.S. (2014) Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 15, 6184-6223. [Google Scholar] [CrossRef] [PubMed]
[29] Holland, W.L., Xia, J.Y., Johnson, J.A., et al. (2017) Inducible Overexpression of Adiponectin Receptors Highlight the Roles of Adiponectin-Induced Ceramidase Signaling in Lipid and Glucose Homeostasis. Molecular Metabolism, 6, 267-275. [Google Scholar] [CrossRef] [PubMed]
[30] Tsochatzis, E., Papatheodoridis, G.V. and Archimandritis, A.J. (2007) The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases. American Journal of Gastroenterology, 18, 2629-2640. [Google Scholar] [CrossRef] [PubMed]
[31] Zhao, S.G. (2018) Effect of Tonifying Kidney and Removing Phlegm on Adiponectin, Leptin, Interleukin-18 and Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver. Chinese Journal of Integrated Traditional & Western Medicine on Digestion, 26, 496-499.
[32] Tardelli, M., Moreno-Viedma, V., Zeyda, M., et al. (2017) Adiponectin Regulates Aquaglyceroporin Expression in Hepatic Stellate Cells Altering Their Functional State. Journal of Gastroenterology & Hepatology, 32, 253-260. [Google Scholar] [CrossRef] [PubMed]
[33] Guo, R., Nair, S., Zhang, Y., et al. (2017) Adiponectin Deficiency Rescues High-Fat Diet-Induced Hepatic Injury, Apoptosis and Autophagy Loss Despite Persistent Steatosis. International Journal of Obesity, 41, 1403-1412. [Google Scholar] [CrossRef] [PubMed]
[34] Sharma, K. (2014) Obesity, Oxidative Stress, and Fibrosis in Chronic Kidney Disease. Kidney International Supplements, 4, 113-117. [Google Scholar] [CrossRef] [PubMed]
[35] Sharma, K., Ramacharaoandr, S., Qiu, G., et al. (2008) Adiponectin Regulates Albuminuria and Podocyte Function in Mice. Journal of Clinical Investigation, 118, 1645-1656. [Google Scholar] [CrossRef
[36] Knight, S.F. and Imig, J.D. (2007) Obesity, Insulin Resistance, and Renal Function. Microcirculation, 14, 349-362. [Google Scholar] [CrossRef] [PubMed]
[37] Kou, H., Deng, J., Gao, D., et al. (2018) Relationship among Adiponectin, Insulin Resistance and Atherosclerosis in Non-Diabetic Hypertensive Patients and Healthy Adults. Clinical and Experimental Hypertension, 40, 1-8. [Google Scholar] [CrossRef] [PubMed]
[38] Sasso, F.C., Pafundi, P.C., Marfella, R., et al. (2019) Adiponectin and Insulin Resistance Are Related to Restenosis and Overall New PCI in Subjects with Normal Glucose Tolerance: The Prospective AIRE Study. Cardiovascular Diabetology, 18, 24-37. [Google Scholar] [CrossRef] [PubMed]
[39] Peverill, W., Powell, L. and Skoien, R. (2014) Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation. International Journal of Molecular Sciences, 15, 8591-8638. [Google Scholar] [CrossRef] [PubMed]
[40] Sumida, Y., Niki, E., Naito, Y., et al. (2013) Involvement of Free Radicals and Oxidative Stress in NAFLD/NASH. Free Radical Research, 47, 869-880. [Google Scholar] [CrossRef] [PubMed]
[41] Mann, J.P., Raponi, M. and Nobili, V. (2017) Clinical Implications of Understanding the Association between Oxidative Stress and Pediatric NAFLD. Expert Review of Gastroenterology & Hepatology, 11, 371-382. [Google Scholar] [CrossRef] [PubMed]
[42] Spahis, S., Delvin, E., Borys, J.M., et al. (2016) Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. Antioxidants & Redox Signaling, 26, 519-541. [Google Scholar] [CrossRef] [PubMed]
[43] Liberal, R., Grant, C.R., Mieli-Vergani, G., et al. (2013) Autoimmune Hepatitis: A Comprehensive Review. Journal of Autoimmunity, 41, 126-139. [Google Scholar] [CrossRef] [PubMed]
[44] Hotamisligil, G.S. (2006) Inflammation and Metabolic Disorders. Current Opinion in Clinical Nutrition & Metabolic Care, 11, 459-464.
[45] Takaki, A., Kawai, D. and Yamamoto, K. (2013) Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences, 14, 20704-20728. [Google Scholar] [CrossRef] [PubMed]
[46] Fujita, N., Miyachi, H., Tanaka, H., et al. (2009) Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis. Cancer Epidemiology Biomarkers & Prevention, 50, S372-S373. [Google Scholar] [CrossRef
[47] Katsoulieris, E., Mabley, J.G., Samai, M., et al. (2010) Lipotoxicity in Renal Proximal Tubular Cells: Relationship between Endoplasmic Reticulum Stress and Oxidative Stress Pathways. Free Radical Biology and Medicine, 48, 1654-1662. [Google Scholar] [CrossRef] [PubMed]
[48] Rong, G., Tang, X., Guo, T., et al. (2015) Advanced Oxidation Protein Products Induce Apoptosis in Podocytes through Induction of Endoplasmic Reticulum Stress. Journal of Physiology & Biochemistry, 71, 455-470. [Google Scholar] [CrossRef] [PubMed]
[49] Boini, K.M., Xia, M., Abais, J.M., et al. (2014) Activation of Inflammasomes in Podocyte Injury of Mice on the High Fat Diet: Effects of ASC Gene Deletion and Silencing. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1843, 836-845. [Google Scholar] [CrossRef] [PubMed]
[50] Masarone, M. (2014) Non Alcoholic Fatty Liver: Epidemiology and Natural History. Reviews on Recent Clinical Trials, 9, 126-133. [Google Scholar] [CrossRef] [PubMed]
[51] Zhang, Q., Li, Y., Liang, T., et al. (2015) ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice. International Journal of Biological Sciences, 11, 559-568. [Google Scholar] [CrossRef] [PubMed]
[52] Fujii, J., Homma, T., Kobayashi, S., et al. (2018) Mutual Interaction between Oxidative Stress and Endoplasmic Reticulum Stress in the Pathogenesis of Diseases Specifically Focusing on Non-Alcoholic Fatty Liver Disease. World Journal of Biological Chemistry, 9, 4-18. [Google Scholar] [CrossRef] [PubMed]
[53] Cunard, R. and Sharma, K. (2011) The Endoplasmic Reticulum Stress Response and Diabetic Kidney Disease. AJP: Renal Physiology, 300, F1054-F1061. [Google Scholar] [CrossRef] [PubMed]
[54] Duan, H.J. (2014) Role of Endoplasmic Reticulum Stress in Apoptosis of Differentiated Mouse Podocytes Induced by High Glucose. International Journal of Molecular Medicine, 33, 809-816. [Google Scholar] [CrossRef] [PubMed]
[55] Kampe, K., Sieber, J., Orellana, J.M., et al. (2014) Susceptibility of Podocytes to Palmitic Acid Is Regulated by Fatty Acid Oxidation and Inversely Depends on Acetyl-CoA Carboxylases 1 and 2. AJP: Renal Physiology, 306, F401-F409. [Google Scholar] [CrossRef] [PubMed]
[56] Sieber, J., Lindenmeyer, M.T., Kampe, K., et al. (2010) Regulation of Podocyte Survival and Endoplasmic Reticulum Stress by Fatty Acids. American Journal of Physiology Renal Physiology, 299, F821-F829. [Google Scholar] [CrossRef] [PubMed]
[57] Garner, K.L., Betin, V.M.S., Pinto, V., et al. (2018) Enhanced Insulin Receptor, But Not PI3K, Signalling Protects Podocytes from ER Stress. Scientific Reports, 8, 3902-3915. [Google Scholar] [CrossRef] [PubMed]
[58] Qiu, M., Li, S., Jin, L., et al. (2018) Combination of Chymostatin and Aliskiren Attenuates ER Stress Induced by Lipid Overload in Kidney Tubular Cells. Lipids in Health and Disease, 17, 183-194. [Google Scholar] [CrossRef] [PubMed]
[59] Parambir, S., Dulai, S.D., Janki, P., et al. (2017) Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Hepatology, 65, 1557-1565. [Google Scholar] [CrossRef] [PubMed]
[60] Adams, L.A., Anstee, et al. (2017) Non-Alcoholic Fatty Liver Disease and Its Relationship with Cardiovascular Disease and Other Extrahepatic Diseases. Gut: Journal of the British Society of Gastroenterology, 66, 1138-1153. [Google Scholar] [CrossRef] [PubMed]